Teva Shopping Around Medis To Ease Debt

Aug 09, 2017

Teva is seeking a buyer for its Medis business as it continues to sells assets to ease its debts, which still total more than $32 billion.

Medis was acquired in 2016 in Teva's acquisition of Actavis, which had led to then-CEO Erez Vigodman's resignatino in February.

Reports from Bloomberg News, indicate that Medis is valued anywhere from $500 million to $1 billion.

Teva is also looking to sell its women's health and European oncology and pain businesses, which could potentially bring down its debt another $2 billion. The Israel-based drug maker plans to pay $5 billion of debt in 2017.

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments